ImaBiotech, a CRO company developing and offering mass spectrometry imaging (MSI) services, applications, and software, announces today a license agreement with Lawrence Berkeley National Laboratory (Berkeley Lab) to "OpenMSI" intellectual property to support ImaBiotech Multimaging™ technology.

First worldwide patent has been granted covering ImaBiotech's research and services platform in the field of Mass spectrometry Imaging (MSI).